Arabic Arabic English English French French German German
dark

23andMe Keeps Snagging FDA Nods for Cancer Marker Tests

The Sunnyvale, CA-based company said it has won FDA clearance for a genetic health risk report on a hereditary prostate cancer marker. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

RefSeq Release 210 is available

Next Post

Wyomingites overwhelmingly want physicians to supervise nurse anesthetists and respond to anesthesia emergencies

Related Posts
Total
0
Share